Aurobindo Pharma Announces Mutual Termination Of Agreement With Sandoz Inc

Aurobindo Pharma Ltd today announced the mutual agreement with Sandoz Inc to terminate the agreement to buy the Sandoz US generic oral solids and dermatology businesses from Sandoz Inc. This decision was taken as approval from the U.S. Federal Trade Commission for the transaction was not obtained within anticipated timelines.

Shares of AUROBINDO PHARMA LTD. was last trading in BSE at Rs.392.15 as compared to the previous close of Rs. 413.05. The total number of shares traded during the day was 146774 in over 3150 trades.

The stock hit an intraday high of Rs. 435 and intraday low of 384.75. The net turnover during the day was Rs. 57897442.-Equity Bulls